Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature

被引:207
作者
Alleman, Cathelijne J. M. [1 ]
Westerhout, Kirsten Y. [1 ]
Hensen, Marja [1 ]
Chambers, Colette [2 ]
Stoker, Malcolm [3 ]
Long, Stephen [4 ]
van Nooten, Floortje E. [3 ]
机构
[1] Pharmerit BV, Rotterdam, Netherlands
[2] Astellas Pharma Europe Ltd, Chertsey, England
[3] Astellas Pharma Europe BV, Leiden, Netherlands
[4] INC Res Ltd, Sutton, Surrey, England
关键词
Literature review; Painful diabetic neuropathy; Epidemiology; Burden; Quality-of-life; Europe; COMMUNITY-TREATED PATIENTS; HEALTH-RELATED UTILITY; COST-EFFECTIVENESS; DIFFERING SEVERITY; USUAL CARE; PREVALENCE; LIFE; IMPACT; PREGABALIN; MANAGEMENT;
D O I
10.1016/j.diabres.2015.04.031
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims: Painful diabetic peripheral neuropathy (PDPN) is a common complication of diabetes mellitus. A systematic literature review was conducted to provide an overview of published literature in the last 10-years on the epidemiology, humanistic burden and economic burden of PDPN in Europe. Methods: A search was performed according to pre-defined strategy and review criteria in Embase, Pubmed, and conference proceedings databases from 2003 till December 2012. In total, 30 publications written in English covering the relevant patient population and topics of interest. Results: European prevalence ranges from 6% to 34% in diabetes mellitus patients. PDPN has a significant humanistic and economic impact. Patients are limited in their general functioning and their ability to sleep and often experience anxiety and depression. Not surprisingly, PDPN is associated with reduced Health-Related-Quality-of-Life (HRQoL). PDPN patients incur high health care costs due to hospitalizations and outpatient visits. In addition, the painful symptoms cause impaired work productivity. Studies suggest both humanistic and economic burden increase with higher pain severity. Conclusions: The burden from PDPN appears to be higher with increasing pain severity. More severe pain leads to a higher impairment in daily functioning, sleep and HRQoL. Higher pain intensity also leads to increasing healthcare costs and work productivity losses. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:215 / 225
页数:11
相关论文
共 58 条
[1]
Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the UK [J].
Abbott, Caroline A. ;
Malik, Rayaz A. ;
van Ross, Ernest R. E. ;
Kulkarni, Jai ;
Boulton, Andrew J. M. .
DIABETES CARE, 2011, 34 (10) :2220-2224
[2]
[Anonymous], EUR J PAIN S
[3]
[Anonymous], PAIN PRACT S1
[4]
[Anonymous], PAIN PRACT S1
[5]
[Anonymous], NICE CLIN GUID 173 N
[6]
[Anonymous], EUR J PAIN S
[7]
[Anonymous], SCHMERZ S
[8]
[Anonymous], XE CURR CONV
[9]
[Anonymous], DIABET MED J BR D S1
[10]
[Anonymous], EQ 5D VALUE SETS INV